VitalWorks revenues drop
IT provider VitalWorks, which last year acquired PACS vendor Amicas, reported a drop in revenues for the fourth quarter ended Dec. 31, compared with both the immediately preceding quarter and the same period a year earlier. The company tallied $26.7
IT provider VitalWorks, which last year acquired PACS vendor Amicas, reported a drop in revenues for the fourth quarter ended Dec. 31, compared with both the immediately preceding quarter and the same period a year earlier. The company tallied $26.7 million, compared with $28.1 million in the preceding quarter (end Sept. 30) and $29 million for the quarter ending Dec. 31, 2002. VitalWorks had a net loss of $2 million for 4Q 2003, compared with net income of $4.1 million for the corresponding 2002 period. On the bright side, deferred revenues rose to $11.8 million as of Dec. 31 from $7.9 million on Sept. 30. Company executives predicted that PACS will drive growth in radiology IT for the next several years, and that the combination of Amicas' PACS and its own radiology products will provide an advantage in this market.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
